We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Fresh off the FDA’s March 1 authorization of Johnson & Johnson’s (J&J) single-shot vaccine, President Biden announced that the U.S. has secured an additional 100 million doses of the shot, doubling its original supply agreement with the company. Read More
House Democrats passed the $1.9 trillion COVID-19 relief bill yesterday in an 220-211 vote along party lines, sending the legislation to President Biden’s desk for signing on Thursday. Read More
A single dose of Pfizer/BioNTech’s vaccine after prior COVID-19 infection may generate the same or higher levels of antibodies as having had two doses of the vaccine, according to a small study led by researchers from NYU Grossman School of Medicine’s Vaccine Center. Read More
EU member states increasingly frustrated with the speed of vaccine rollouts are going it alone through separate authorizations and side deals for vaccines from Russia and China. Read More
Eli Lilly said its combination antibody therapy, bamlanivimab and etesevimab, reduced the risk of hospitalization and death by 87 percent in a late-stage study of 769 high-risk COVID-19 patients — and worked against emerging variant strains of the coronavirus. Read More
Bharat Biotech’s Covaxin (BBV152), the first successful COVID-19 vaccine developed in India, showed high levels of antibody response and no serious side effects in a phase 2 study, researchers reported in The Lancet. Read More
The Pfizer/BioNTech COVID-19 vaccine demonstrated effectiveness against a Brazilian coronavirus strain that has quickly spread throughout the country, a study has found. Read More
Aura automatically displays a warning to Empatica’s smartphone-based Care App, as well as a cloud-based portal, and can be set up to inform healthcare providers or caregivers. Read More
During its first week of shipments, the COVAX global vaccine-sharing scheme distributed 20 million vaccine doses to 20 countries, World Health Organization Director-General Tedros Adhanom Ghebreyesus said. Vaccine distributions began in late February starting with India, Ghana and Cote d’Ivoire. Read More
Moderna has struck a deal with Baxter International to perform fill and finish work for an estimated 60 to 90 million doses of Moderna’s COVID-19 vaccine in 2021 at its plant in Bloomington, Indiana. Read More
Merck and Ridgeback Biotherapeutics have said their experimental COVID-19 antiviral MK-4482 (molnupiravir) significantly reduced infection after five days of treatment in a clinical trial. Read More